1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025

  • 79 pages, published in January 2017
  • By GlobalData
  • Report Number: 3321282

Summary

Table of Contents

Search Inside

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025

Summary

Human immunodeficiency virus (HIV) is a lentivirus that impairs and destructs the CD4 cells of the immune system. This weakens the immune system, leaving an infected individual more susceptible to other illnesses and, over time, impairing the individual’s ability to fight off infections.

GlobalData epidemiologists utilized national and international HIV and AIDS databases, surveillance data, and robust peer-reviews journal articles to build the forecast of total prevalent and diagnosed prevalent cases of HIV in the 8MM. HIV is defined as an infection with HIV, regardless of the stage of disease. This corresponds to the International Classification of Diseases 10th edition (ICD-10) code B20. Diagnosed prevalent cases of HIV were segmented by age and sex using country-specific data, whenever available; when data were not available, appropriate proxies were used. For Japan, GlobalData epidemiologists provided an alternative forecast for the 20-year diagnosed prevalent cases of HIV, which better aligns with the ART market sales data after consolidation. GlobalData epidemiologists also provide an alternative forecast for Japan in the EpiCast model based on the reported prevalent HIV cases.

GlobalData epidemiologists forecast that the total prevalent cases of HIV in the 8MM will increase from 3,632,410 in 2015 to 4,266,548 in 2025 at an Annual Growth Rate (AGR) of 1.75%. The US will have the highest number of total prevalent cases of HIV in both 2015 and 2025 at 1,315,263 and 1,514,925, respectively. GlobalData epidemiologists forecast that the diagnosed prevalent cases of HIV in the 8MM will increase from 2,926,335 in 2015 to 3,616,811 in 2025 at an AGR of 2.36%. In Japan, GlobalData epidemiologists forecast the 20-year diagnosed prevalent cases of HIV to increase from 20,438 in 2015 to 25,417 in 2025 at an AGR of 2.44%.

Scope

- The Humman Immunodeficiency Virus (HIV) EpiCast Report provides an overview of the risk factors and global trends for HIV in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Brazil, and China). For the 8MM (US, France, Germany, Italy, Spain, UK, Brazil, and China) it also includes a 10-year epidemiological forecast for the total prevalent cases of HIV (both sexes and all ages), and diagnosed prevalent cases of HIV segmented by sex and age from 2015-2025. The diagnosed prevalent cases of HIV are further segmented into those receiving antiretroviral therapy (ART), those with hepatitis B virus (HBV) co-infection, and those with hepatitis C virus (HCV) co-infection. For Japan, GlobalData epidemiologists provide a 10-year forecast for the 20-year diagnosed prevalent cases of HIV segmented by sex and age from 2015-2025. The 20-year diagnosed prevalent cases of HIV are further segmented into those receiving ART, those with HBV co-infection, and those with HCV co-infection.
- The HIV epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

The HIV EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global HIV market.
- Quantify patient populations in the global HIV market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for HIV therapeutics in each of the markets covered.
- Understand co-infection population and ART treated population for HIV patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you get this report now

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers
HIV Diagnosis Market by Test Type, Viral Load, CD4 Count, Early Infant, Viral Identification, Product, End User - Global Forecast to 2021

HIV Diagnosis Market by Test Type, Viral Load, CD4 Count, Early Infant, Viral Identification, Product, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The HIV diagnosis market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.5% from 2016 to 2021. The global HIV diagnosis market is segmented based on product, ...

2017 World Blood Typing, Grouping and Infectious Disease NAT Screening Market: Sales and Market Shares of Major Suppliers by Test and Country

2017 World Blood Typing, Grouping and Infectious Disease NAT Screening Market: Sales and Market Shares of Major Suppliers by Test and Country

  • $ 5450
  • Industry report
  • March 2017
  • by Venture Planning Group

This unique report from VPGMarketResearch provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report ...

2017 Roche: Diagnostics Sales, Market Shares and Competitive Position by Product and Country

2017 Roche: Diagnostics Sales, Market Shares and Competitive Position by Product and Country

  • $ 5000
  • Industry report
  • March 2017
  • by Venture Planning Group

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product ...


Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics

  • May 2017
    172 pages
  • Infectious Dise...  

    Hospital  

  • United States  

    Asia  

    North America  

View report >

Biopharmaceutical Industry in the US

  • May 2017
    4 pages
  • Biopharmaceutic...  

    Respiratory Dis...  

    Therapy  

  • United States  

View report >

Global Infectious Disease Statistics

  • May 2017
    40 pages
  • Tuberculosis  

    Infectious Dise...  

    HIV AIDS  

  • World  

View report >

Related Market Segments :

HIV AIDS
HIV Antiviral

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.